https://www.swinburne.edu.au/news/2023/01/Australias-biggest-research-trial-using-psychedelics-to-treat-depression-to-commence-in-2023/
Swinburne has signed a $5 million clinical trial research agreement with Woke Pharmaceuticals to embark on Australia’s biggest research trial examining the promise of the active ingredient in psychedelic mushrooms, called ‘psilocybin’, in tackling treatment-r…
Create an account or login to join the discussion